ResearcherThe University of SydneyNo recent work listed
Malinda Itchins
Matched on ORCID iD 0000-0002-2741-8250; OpenAlex author ID A5000949291. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper
Papers 6
- The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as B… Co-author DOI 10.3390/jcm12051989↗
- The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resect… Co-author DOI 10.3390/cancers14153620↗
- Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis. First author DOI 10.3390/jcm10122700↗
- Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001472↗
- Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study. Co-author DOI 10.1016/j.ejso.2018.10.050↗
- Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume r… Co-author DOI 10.1016/j.ejso.2017.06.012↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stephen John Clarke · 6 shared papers, 2017–2023 · strength 0.65
- Paper The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and… DOI 10.3390/jcm12051989↗
- Paper The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Manage… DOI 10.3390/cancers14153620↗
- Paper Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Ana… DOI 10.3390/jcm10122700↗
- Jaswinder Singh Samra · 6 shared papers, 2017–2023 · strength 0.65
- Paper The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and… DOI 10.3390/jcm12051989↗
- Paper The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Manage… DOI 10.3390/cancers14153620↗
- Paper Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Ana… DOI 10.3390/jcm10122700↗
- Nick Pavlakis · 6 shared papers, 2017–2023 · strength 0.65
- Paper The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and… DOI 10.3390/jcm12051989↗
- Paper The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Manage… DOI 10.3390/cancers14153620↗
- Paper Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Ana… DOI 10.3390/jcm10122700↗
- Anthony James Gill · 6 shared papers, 2017–2023 · strength 0.65
- Paper The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and… DOI 10.3390/jcm12051989↗
- Paper The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Manage… DOI 10.3390/cancers14153620↗
- Paper Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Ana… DOI 10.3390/jcm10122700↗
- Anubhav Mittal · 6 shared papers, 2017–2023 · strength 0.65
- Paper The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and… DOI 10.3390/jcm12051989↗
- Paper The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Manage… DOI 10.3390/cancers14153620↗
- Paper Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Ana… DOI 10.3390/jcm10122700↗
- Sumit Sahni · 3 shared papers, 2021–2023 · strength 0.42
- Paper The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and… DOI 10.3390/jcm12051989↗
- Paper The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Manage… DOI 10.3390/cancers14153620↗
- Paper Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Ana… DOI 10.3390/jcm10122700↗
- Emily K. Colvin · 3 shared papers, 2019–2023 · strength 0.38
- Paper The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and… DOI 10.3390/jcm12051989↗
- Paper The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Manage… DOI 10.3390/cancers14153620↗
- Paper Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort stu… DOI 10.1016/j.ejso.2018.10.050↗
- Christopher Bahdah Nahm · 4 shared papers, 2017–2022 · strength 0.36
- Paper The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Manage… DOI 10.3390/cancers14153620↗
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Paper Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort stu… DOI 10.1016/j.ejso.2018.10.050↗
- Sarah Maloney · 2 shared papers, 2021–2023 · strength 0.29
- Paper The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and… DOI 10.3390/jcm12051989↗
- Paper Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Ana… DOI 10.3390/jcm10122700↗
- Nigel Balfour Jamieson · 2 shared papers, 2019–2020 · strength 0.18
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Paper Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort stu… DOI 10.1016/j.ejso.2018.10.050↗
- David Lok Hang Chan · 1 shared paper, 2023 · strength 0.16
- Terence C. Chua · 2 shared papers, 2017–2020 · strength 0.15
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Paper Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic … DOI 10.1016/j.ejso.2017.06.012↗
- George Hruby · 2 shared papers, 2017–2020 · strength 0.15
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Paper Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic … DOI 10.1016/j.ejso.2017.06.012↗
- Angela S. Y. Chou · 1 shared paper, 2022 · strength 0.13
- Matthew H. Wong · 1 shared paper, 2017 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.